Professor Andrew Shaw is Founder & CEO of the multi-award-winning diagnostics company, Attomarker. The business describes itself as being “dedicated to the personalised medicine market, providing gold-standard rapid diagnostics that facilitate better and timelier health decisions.” Prof Shaw describes himself as “an academic entrepreneur”, attributing this to encouragement he received at Stamford University, (where he studied) and which instils in all its students a link between science and entrepreneurship, between having a great idea and commercialising it.
Attomarker’s capital value is currently around £30m. Prof Shaw, now in his 50s, is an associate professor of physical chemistry at Exeter University, which is where Attomarker started. He is also a Fellow of the Royal Astronomical Society and a Fellow of the Royal Society of Chemistry. As an eminent scientist and academic entrepreneur, Prof Shaw has dedicated his work to advancing science and helping doctors in the treatment of their patients.
Hosted on Acast. See acast.com/privacy for more information.
